Skip to main content

Series A Biotechnology Companies

Explore 772 biotechnology startups that raised series a funding. Access verified founder contact information and fundraising data.

Total Companies
772
Total Funding
$1.6B
Avg Funding
$65.2M
Cities
19

Export 772 Series A Biotechnology Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
San Diego, United States
$180.0M
raised

cAMPfield Therapeutics is a biotechnology company that specializes on exploration and development activities of therapeutic solutions.

May 2026
Series A

Founder Contacts

30,000+ verified contacts

Houston, United States
$30.0M
raised

Oorja Bio is is a clinical-stage biotechnology company focused on developing therapies.

May 2026
Series A

Founder Contacts

30,000+ verified contacts

Boston, United States
$177.0M
raised

Antares is a biotechnology company focused on developing transformational,medicines targeting validated cancer and other serious diseases.

May 2025
Series A

Founder Contacts

30,000+ verified contacts

Malvern, United States
$300.0M
raised

Uniquity Bio is a clinical-stage drug development company focused on advancing scientific innovation and delivering novel medicines.

May 2024
Series A

Founder Contacts

30,000+ verified contacts

Ghent, Belgium
$43.5M
raised

Dualyx engages in the discovery and development of biologicals for the treatment of autoimmune and rare diseases.

May 2023
Series A

Founder Contacts

30,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 772 funded startups

30,000+ verified emails
Unlimited exports
No credit card required
Birmingham, United States
$20.0M
raised

Immunowake is a biotechnology company that focuses on identifying new therapies for patients who do not respond to existing immunotherapies.

May 2022
Series A

Founder Contacts

30,000+ verified contacts

South San Francisco, United States
$75.0M
raised

Initial Therapeutics is a developer of small-molecule medicines designed to prevent pathogenic protein synthesis.

May 2023
Series A

Founder Contacts

30,000+ verified contacts

Cambridge, United States
$85.0M
raised

Stylus Medicine is on a quest to create disease-treating agents for the next generation based on the groundbreaking work of its founders.

May 2025
Series A

Founder Contacts

30,000+ verified contacts

Palo Alto, United States
$35.0M
raised

Developing the first global biosecurity platform to provide enterprises a SaaS-enabled service for the management of bio-risks.

May 2022
Series A

Founder Contacts

30,000+ verified contacts

Epalinges, Switzerland
$50.3M
raised

NewBiologix operates as a technology innovation company.

May 2023
Series A

Founder Contacts

30,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 772 funded startups

30,000+ verified emails
Unlimited exports
No credit card required
Cambridge, United States
$121.0M
raised

Merida Biosciences is a biotech company focused on developing precision treatments, particularly for autoimmune diseases.

Apr 2025
Series A

Founder Contacts

30,000+ verified contacts

Menlo Park, United States
$60.0M
raised

Enable medicine is a biotechnology company that develops biological cartography tools to generate cellular maps that help in drug discovery.

Apr 2022
Series A

Founder Contacts

30,000+ verified contacts

Cambridge, United Kingdom
$16.0M
raised

The food chain is broken. Our technology fixes it.

Apr 2022
Series A

Founder Contacts

30,000+ verified contacts

Seattle, United States
$9.7M
raised

Receptor Life Sciences is a biotechnology company

Apr 2022
Series A

Founder Contacts

30,000+ verified contacts

Cambridge, United States
$100.0M
raised

Stipple Bio is a biotechnology company that offers cellular profiling and target discovery with epitope resolution.

Apr 2026
Series A

Founder Contacts

30,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 772 funded startups

30,000+ verified emails
Unlimited exports
No credit card required
New York, United States
$11.6M
raised

Acuamark develops technology that allows for highly accurate screening of blood to detect cancer markers at early cancer stages.

Apr 2022
Series A

Founder Contacts

30,000+ verified contacts

Birmingham, United Kingdom
$2.9M
raised

Adapttech develops ingenious biomedical technologies to help people with physical limitations improve their quality of life

Apr 2022
Series A

Founder Contacts

30,000+ verified contacts

Somerville, United States
$24.5M
raised

Summation Bio is a gene therapy company that develops a novel non-viral gene transfer technology.

Apr 2022
Series A

Founder Contacts

30,000+ verified contacts

Grand Cayman, Cayman Islands

D2M Biotherapeutics focuses on the development of novel immunotherapeutics.

Apr 2023
Series A

Founder Contacts

30,000+ verified contacts

Solna, Sweden
$20.0M
raised

Moleculent is the Biotechnology Research company.

Apr 2026
Series A

Founder Contacts

30,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 772 funded startups

30,000+ verified emails
Unlimited exports
No credit card required
Laguna Hills, United States
$35.0M
raised

Aureka Biotechnologies is a pioneering biotech firm dedicated to democratizing the pharmaceutical sector in order to conquer sickness.

Apr 2026
Series A

Founder Contacts

30,000+ verified contacts

Munich, Germany
$12.0M
raised

mbiomics is a biotechnology company.

Apr 2026
Series A

Founder Contacts

30,000+ verified contacts

Heverlee, Belgium
$125.0M
raised

CoultreonBiopharma is developing best-in-class therapeutics that target clinically validated pathways in immunology and metabolic illnesses.

Apr 2026
Series A

Founder Contacts

30,000+ verified contacts

Boston, United States
$50.0M
raised

Kelonia Therapeutics develops genetic medicines focused on in vivo gene delivery and cell therapy for cancer and other diseases.

Apr 2022
Series A

Founder Contacts

30,000+ verified contacts

New York, United States
$47.0M
raised

Fathom Therapeutics focuses on drug design by harnessing biomolecular motion to develop therapeutics that can reprogram protein function.

Apr 2026
Series A

Founder Contacts

30,000+ verified contacts

Showing 176 to 200 of 772 companies

Ready to Connect with Series A Biotechnology Startups?

Get verified founder emails, funding details, and company data for 772 series a biotechnology companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked

772 Biotechnology Series A Startups (August 2026) — Page 8 | VCBacked